A Study of LY3549492 in Japanese Participants With Type 2 Diabetes Mellitus (T2D) and Healthy Japanese Participants

Inclusion Criteria:

Part A:

• Participants with T2DM for at least 6 months

• With an HbA1c value:

• equal to or greater than 7.0% and equal to or less than 10.0% at screening forparticipants treated with diet and exercise alone, OR

• equal to or greater than 6.5% and equal to or less than 9.0% for participantsprior to washout of antidiabetic medications

• Have had a stable weight for the 3 months prior to screening. Stable weight isdefined as less than 5% body weight change

Part B:

• Have safety laboratory test results within normal reference range for the populationor investigative site, or results with acceptable deviations that are judged to benot clinically significant by the investigator. Laboratory tests may be repeated ifthere is a documented technical error, or once at the discretion of the investigatorfor any out-of-range results

Exclusion Criteria:

• Have a known clinically significant gastric emptying abnormality

• Have a 12-lead electrocardiogram (ECG) abnormality

• Have an abnormal blood pressure or pulse rate

• Have a significant history within the past 6 months or current evidence ofcomorbidities capable of altering the absorption, metabolism, or elimination ofdrug. Or constituting a risk when taking the study drug

• Have a history of chronic medical conditions involving the heart, liver, or kidneys